• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于高通量筛选靶向gp41的HIV-1融合抑制剂的快速自动化荧光酶联免疫吸附测定法。

Rapid and automated fluorescence-linked immunosorbent assay for high-throughput screening of HIV-1 fusion inhibitors targeting gp41.

作者信息

Liu Shuwen, Boyer-Chatenet Louise, Lu Hong, Jiang Shibo

机构信息

Lindsley F. Kimball Research Institute, New York Blood Center, New York, NY 10021, USA.

出版信息

J Biomol Screen. 2003 Dec;8(6):685-93. doi: 10.1177/1087057103259155.

DOI:10.1177/1087057103259155
PMID:14711394
Abstract

The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp41 plays an important role in the virus entry. During the process of fusion between the viral and target cell membranes, the N- and C-terminal heptad repeat (HR) regions of the gp41 extracellular domain associate to form a 6-helical bundle, corresponding to the fusion-active gp41 core. Any compound that blocks the gp41 6-helix bundle formation between the N- and C-peptides, which are derived from the N- and C-terminal HR regions, respectively, may inhibit HIV-1 mediated membrane fusion. Based on this principle, we previously established a sandwich enzyme-linked immunosorbent assay (ELISA) for drug screening by using the N-peptide N36 and the C-peptide C34 and a monoclonal antibody (NC-1) which specifically recognizes the gp41 6-helix bundle. In the present study, a fluorescence-linked immunosorbent assay (FLISA) was developed by using fluorescein isothiocyanate (FITC)-conjugated C34 to replace C34 and by directly detecting fluorescence intensity instead of more complicated enzymatic reaction. Compared with the sandwich ELISA, this FLISA has similar sensitivity and specificity, but it is much more rapid, economic and convenient. Using an Integrated Robotic Sample Processing System, this assay has been applied for high-throughput screening of organic compounds on a large scale for HIV-1 fusion inhibitors targeting gp41.

摘要

人类免疫缺陷病毒1型(HIV-1)包膜糖蛋白gp41在病毒进入过程中起重要作用。在病毒与靶细胞膜融合过程中,gp41胞外域的N端和C端七肽重复(HR)区域相互作用形成一个6螺旋束,即融合活性gp41核心。任何阻断分别源自N端和C端HR区域的N肽和C肽之间gp41 6螺旋束形成的化合物,都可能抑制HIV-1介导的膜融合。基于这一原理,我们之前利用N肽N36、C肽C34和一种特异性识别gp41 6螺旋束的单克隆抗体(NC-1)建立了一种用于药物筛选的夹心酶联免疫吸附测定(ELISA)。在本研究中,通过使用异硫氰酸荧光素(FITC)偶联的C34替代C34,并直接检测荧光强度而非更复杂的酶促反应,开发了一种荧光免疫吸附测定(FLISA)。与夹心ELISA相比,这种FLISA具有相似的灵敏度和特异性,但速度更快、更经济且更方便。利用集成机器人样品处理系统,该测定已被应用于大规模高通量筛选针对gp41的HIV-1融合抑制剂的有机化合物。

相似文献

1
Rapid and automated fluorescence-linked immunosorbent assay for high-throughput screening of HIV-1 fusion inhibitors targeting gp41.用于高通量筛选靶向gp41的HIV-1融合抑制剂的快速自动化荧光酶联免疫吸附测定法。
J Biomol Screen. 2003 Dec;8(6):685-93. doi: 10.1177/1087057103259155.
2
A novel enzyme-linked immunosorbent assay for screening HIV-1 fusion inhibitors targeting HIV-1 Gp41 core structure.一种用于筛选靶向HIV-1 Gp41核心结构的HIV-1融合抑制剂的新型酶联免疫吸附测定法。
J Biomol Screen. 2011 Feb;16(2):221-9. doi: 10.1177/1087057110393333.
3
High-throughput screening method of inhibitors that block the interaction between 2 helical regions of HIV-1 gp41.阻断HIV-1 gp41两个螺旋区域之间相互作用的抑制剂的高通量筛选方法
J Biomol Screen. 2005 Feb;10(1):13-9. doi: 10.1177/1087057104269726.
4
The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.完整包膜糖蛋白的稳定性是HIV/SIV对肽类融合抑制剂敏感性的主要决定因素。
J Mol Biol. 2004 Jun 25;340(1):9-14. doi: 10.1016/j.jmb.2004.04.027.
5
A mammalian two-hybrid system-based assay for small-molecular HIV fusion inhibitors targeting gp41.基于哺乳动物双杂交系统的抗 HIV 融合抑制剂小分子药物筛选方法,该抑制剂作用靶点为 gp41。
Antiviral Res. 2011 Apr;90(1):54-63. doi: 10.1016/j.antiviral.2011.02.006. Epub 2011 Feb 23.
6
Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended.HIV-1 gp41胞外域区域在磷脂膜中的功能和结构表征表明,融合活性构象是伸展的。
J Mol Biol. 2006 Dec 15;364(5):1103-17. doi: 10.1016/j.jmb.2006.08.091. Epub 2006 Sep 5.
7
A time-resolved fluorescence assay to identify small-molecule inhibitors of HIV-1 fusion.一种用于鉴定HIV-1融合小分子抑制剂的时间分辨荧光测定法。
J Biomol Screen. 2007 Sep;12(6):865-74. doi: 10.1177/1087057107304645. Epub 2007 Jul 20.
8
Temperature-dependent intermediates in HIV-1 envelope glycoprotein-mediated fusion revealed by inhibitors that target N- and C-terminal helical regions of HIV-1 gp41.靶向HIV-1 gp41 N端和C端螺旋区域的抑制剂揭示了HIV-1包膜糖蛋白介导融合过程中与温度相关的中间体。
Biochemistry. 2004 Jun 29;43(25):8230-3. doi: 10.1021/bi049957v.
9
Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41.设计和评估与人类免疫缺陷病毒 1 型包膜糖蛋白 gp41 的 C 末端七肽重复区 (C-HR) 相对应的抗逆转录病毒肽。
Virology. 2010 Sep 15;405(1):157-64. doi: 10.1016/j.virol.2010.06.012. Epub 2010 Jul 2.
10
Identification of critical antibody-binding sites in the HIV-1 gp41 six-helix bundle core as potential targets for HIV-1 fusion inhibitors.鉴定HIV-1 gp41六螺旋束核心中的关键抗体结合位点作为HIV-1融合抑制剂的潜在靶点。
Immunobiology. 2009;214(1):51-60. doi: 10.1016/j.imbio.2008.04.005. Epub 2008 Jun 17.

引用本文的文献

1
Establishment of a Rapid and Convenient Fluoroimmunoassay Platform Using Antibodies Against PDL1 and HER2.利用抗程序性死亡受体1(PDL1)和人表皮生长因子受体2(HER2)抗体建立快速便捷的荧光免疫分析平台
Curr Issues Mol Biol. 2025 Jan 17;47(1):62. doi: 10.3390/cimb47010062.
2
Semi-automation of process analytics reduces operator effect.工艺分析的半自动操作降低了操作人员的影响。
Bioprocess Biosyst Eng. 2020 May;43(5):753-764. doi: 10.1007/s00449-019-02254-y. Epub 2019 Dec 7.
3
N-Substituted Pyrrole Derivative 12m Inhibits HIV-1 Entry by Targeting Gp41 of HIV-1 Envelope Glycoprotein.
N-取代吡咯衍生物12m通过靶向HIV-1包膜糖蛋白的Gp41抑制HIV-1进入。
Front Pharmacol. 2019 Aug 2;10:859. doi: 10.3389/fphar.2019.00859. eCollection 2019.
4
Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting gp120 or gp41.基于蛋白质和肽的 HIV 进入抑制剂的开发,针对 gp120 或 gp41。
Viruses. 2019 Aug 1;11(8):705. doi: 10.3390/v11080705.
5
In vitro methods for testing antiviral drugs.抗病毒药物的体外检测方法。
Biotechnol Adv. 2018 May-Jun;36(3):557-576. doi: 10.1016/j.biotechadv.2017.12.016. Epub 2017 Dec 29.
6
Screening and Functional Profiling of Small-Molecule HIV-1 Entry and Fusion Inhibitors.小分子HIV-1进入和融合抑制剂的筛选及功能分析
Assay Drug Dev Technol. 2017 Feb/Mar;15(2):53-63. doi: 10.1089/adt.2017.777.
7
Applications of Replicating-Competent Reporter-Expressing Viruses in Diagnostic and Molecular Virology.具有复制能力的报告基因表达病毒在诊断和分子病毒学中的应用
Viruses. 2016 May 6;8(5):127. doi: 10.3390/v8050127.
8
Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.特异性靶向gp120或gp41的小分子HIV进入抑制剂的研发
Curr Top Med Chem. 2016;16(10):1074-90. doi: 10.2174/1568026615666150901114527.
9
High-Throughput HIV-Cell Fusion Assay for Discovery of Virus Entry Inhibitors.用于发现病毒进入抑制剂的高通量HIV细胞融合测定法。
Assay Drug Dev Technol. 2015 Apr;13(3):155-66. doi: 10.1089/adt.2015.639. Epub 2015 Apr 14.
10
Approaches for identification of HIV-1 entry inhibitors targeting gp41 pocket.针对 gp41 口袋的 HIV-1 进入抑制剂的鉴定方法。
Viruses. 2013 Jan 11;5(1):127-49. doi: 10.3390/v5010127.